Intestinal Myofibroblasts: Targets for Stem Cell Therapy

Overview

Journal Am J Physiol Gastrointest Liver Physiol

Publisher American Physiological Society

Specialties Gastroenterology
Physiology

Date 2011 Jan 22

PMID 21252048

Citations 77

Authors

R C Mifflin

I V Pinchuk

J I Saada

D W Powell

Affiliations

Soon will be listed here.

Abstract

The subepithelial intestinal myofibroblast is an important cell orchestrating many diverse functions in the intestine and is involved in growth and repair, tumorigenesis, inflammation, and fibrosis. The myofibroblast is but one of several α-smooth muscle actin-positive (α-SMA(+)) mesenchymal cells present within the intestinal lamina propria, including vascular pericytes, bone marrow-derived stem cells (mesenchymal stem cells or hematopoietic stem cells), muscularis mucosae, and the lymphatic pericytes (colon) and organized smooth muscle (small intestine) associated with the lymphatic lacteals. These other mesenchymal cells perform many of the functions previously attributed to subepithelial myofibroblasts. This review discusses the definition of a myofibroblast and reconsiders whether the α-SMA(+) subepithelial cells in the intestine are myofibroblasts or other types of mesenchymal cells, i.e., pericytes. Current information about specific, or not so specific, molecular markers of lamina propria mesenchymal cells is reviewed, as well as the origins of intestinal myofibroblasts and pericytes in the intestinal lamina propria and their replenishment after injury. Current concepts and research on stem cell therapy for intestinal inflammation are summarized. Information about the stem cell origin of intestinal stromal cells may inform future stem cell therapies to treat human inflammatory bowel disease (IBD).

Citing Articles

Phytochemical Compounds as Promising Therapeutics for Intestinal Fibrosis in Inflammatory Bowel Disease: A Critical Review.

Touny A, Venkataraman B, Ojha S, Pessia M, Subramanian V, Hariharagowdru S Nutrients. 2024; 16(21).

PMID: 39519465 PMC: 11547603. DOI: 10.3390/nu16213633.

Human intestinal stromal cells promote homeostasis in normal mucosa but inflammation in Crohn's disease in a retinoic acid-deficient manner.

Smythies L, Belyaeva O, Alexander K, Bimczok D, Nick H, Serrano C Mucosal Immunol. 2024; 17(5):958-972.

PMID: 38945396 PMC: 11530961. DOI: 10.1016/j.mucimm.2024.06.009.

Systematic dissection of tumor-normal single-cell ecosystems across a thousand tumors of 30 cancer types.

Kang J, Lee J, Cha H, An J, Kwon J, Lee S Nat Commun. 2024; 15(1):4067.

PMID: 38744958 PMC: 11094150. DOI: 10.1038/s41467-024-48310-4.

Chronic arsenic exposure affects stromal cells and signaling in the small intestine in a sex-specific manner.

Ventrello S, McMurry N, Edwards N, Bain L Toxicol Sci. 2024; 198(2):303-315.

PMID: 38310360 PMC: 10964740. DOI: 10.1093/toxsci/kfae016.

Towards Full Thickness Small Intestinal Models: Incorporation of Stromal Cells.

Asal M, Rep M, Bontkes H, van Vliet S, Mebius R, Gibbs S Tissue Eng Regen Med. 2023; 21(3):369-377.

PMID: 38113015 PMC: 10987430. DOI: 10.1007/s13770-023-00600-6.

References

Tischler V, Fritzsche F, Wild P, Stephan C, Seifert H, Riener M . Periostin is up-regulated in high grade and high stage prostate cancer. BMC Cancer. 2010; 10:273. PMC: 2903527. DOI: 10.1186/1471-2407-10-273. View

Marsh M, Trier J . Morphology and cell proliferation of subepithelial fibroblasts in adult mouse jejunum. II. Radioautographic studies. Gastroenterology. 1974; 67(4):636-45. View

Pinchuk I, Mifflin R, Saada J, Powell D . Intestinal mesenchymal cells. Curr Gastroenterol Rep. 2010; 12(5):310-8. PMC: 2975955. DOI: 10.1007/s11894-010-0135-y. View

Rovedatti L, Di Sabatino A, Knowles C, Sengupta N, Biancheri P, Corazza G . Fibroblast activation protein expression in Crohn's disease strictures. Inflamm Bowel Dis. 2010; 17(5):1251-3. DOI: 10.1002/ibd.21446. View

Rieder F, Fiocchi C . Intestinal fibrosis in IBD--a dynamic, multifactorial process. Nat Rev Gastroenterol Hepatol. 2009; 6(4):228-35. DOI: 10.1038/nrgastro.2009.31. View

Katakai T, Hara T, Lee J, Gonda H, Sugai M, Shimizu A . A novel reticular stromal structure in lymph node cortex: an immuno-platform for interactions among dendritic cells, T cells and B cells. Int Immunol. 2004; 16(8):1133-42. DOI: 10.1093/intimm/dxh113. View

Valentich J, Popov V, Saada J, Powell D . Phenotypic characterization of an intestinal subepithelial myofibroblast cell line. Am J Physiol. 1997; 272(5 Pt 1):C1513-24. DOI: 10.1152/ajpcell.1997.272.5.C1513. View

Lee S, Jang A, Kim Y, Cha J, Kim T, Jung S . Modulation of cytokine and nitric oxide by mesenchymal stem cell transfer in lung injury/fibrosis. Respir Res. 2010; 11:16. PMC: 2827393. DOI: 10.1186/1465-9921-11-16. View

Cheng J, Dunbrack Jr R, Valianou M, Rogatko A, Alpaugh R, Weiner L . Promotion of tumor growth by murine fibroblast activation protein, a serine protease, in an animal model. Cancer Res. 2002; 62(16):4767-72. View

10.

Matsumoto T, Okamoto R, Yajima T, Mori T, Okamoto S, Ikeda Y . Increase of bone marrow-derived secretory lineage epithelial cells during regeneration in the human intestine. Gastroenterology. 2005; 128(7):1851-67. DOI: 10.1053/j.gastro.2005.03.085. View

11.

Krueger M, Bechmann I . CNS pericytes: concepts, misconceptions, and a way out. Glia. 2009; 58(1):1-10. DOI: 10.1002/glia.20898. View

12.

Adegboyega P, Mifflin R, DiMari J, Saada J, Powell D . Immunohistochemical study of myofibroblasts in normal colonic mucosa, hyperplastic polyps, and adenomatous colorectal polyps. Arch Pathol Lab Med. 2002; 126(7):829-36. DOI: 10.5858/2002-126-0829-ISOMIN. View

13.

Desaki J, Fujiwara T, Komuro T . A cellular reticulum of fibroblast-like cells in the rat intestine: scanning and transmission electron microscopy. Arch Histol Jpn. 1984; 47(2):179-86. DOI: 10.1679/aohc.47.179. View

14.

Rege T, Hagood J . Thy-1 as a regulator of cell-cell and cell-matrix interactions in axon regeneration, apoptosis, adhesion, migration, cancer, and fibrosis. FASEB J. 2006; 20(8):1045-54. DOI: 10.1096/fj.05-5460rev. View

15.

Jones S, Horwood N, Cope A, Dazzi F . The antiproliferative effect of mesenchymal stem cells is a fundamental property shared by all stromal cells. J Immunol. 2007; 179(5):2824-31. DOI: 10.4049/jimmunol.179.5.2824. View

16.

Chan J, Tang K, Patel A, Bonilla L, Pierobon N, Ponzio N . Antigen-presenting property of mesenchymal stem cells occurs during a narrow window at low levels of interferon-gamma. Blood. 2006; 107(12):4817-24. PMC: 1895812. DOI: 10.1182/blood-2006-01-0057. View

17.

Andoh A, Bamba S, Brittan M, Fujiyama Y, Wright N . Role of intestinal subepithelial myofibroblasts in inflammation and regenerative response in the gut. Pharmacol Ther. 2007; 114(1):94-106. DOI: 10.1016/j.pharmthera.2006.12.004. View

18.

Garcia-Bosch O, Ricart E, Panes J . Review article: stem cell therapies for inflammatory bowel disease - efficacy and safety. Aliment Pharmacol Ther. 2010; 32(8):939-52. DOI: 10.1111/j.1365-2036.2010.04439.x. View

19.

Lanzoni G, Roda G, Belluzzi A, Roda E, Bagnara G . Inflammatory bowel disease: Moving toward a stem cell-based therapy. World J Gastroenterol. 2008; 14(29):4616-26. PMC: 2738785. DOI: 10.3748/wjg.14.4616. View

20.

Wilm B, Ipenberg A, Hastie N, Burch J, Bader D . The serosal mesothelium is a major source of smooth muscle cells of the gut vasculature. Development. 2005; 132(23):5317-28. DOI: 10.1242/dev.02141. View